Skip to main content

Advertisement

Log in

Influence of Frailty in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography for Biliary Stone Disease: A Nationwide Study

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background and Aims

Pancreaticobiliary diseases are common in the elderly. To this end, frailty represents a state of vulnerability that should be considered when assessing the risks and benefits of therapeutic endoscopic procedures. We aim to determine the rate of readmissions and clinical outcomes using the validated Hospital Frailty Risk Score in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP).

Methods

Using the National Readmissions Database, we identified patients with an admission diagnosis of cholangitis with obstructive stone from 2016 to 2019. Patients were determined to be of low frailty risk with a score of < 5, while patients of medium to high frailty risk had a score of > 5.

Results

During the study period, 5751 patients were identified with acute cholangitis with obstructing stone. Mean age of index admissions was 69.4 years and 51.8% were female. From the total cohort, 5119 (89.2%) patients underwent therapeutic ERCP, 38.0% (n = 1947) of whom were regarded as frail (risk score > 5). Following ERCP, frail patients had a less but statistically insignificant readmission rate compared to non-frail patients (2.76% vs 4.05%, p = 0.450). However, compared to non-frail patients, frail patients experienced higher post-ERCP complications (6.20% vs 14.63%, p < 0.001). Frail patients were more likely to have longer lengths of stay, higher hospital cost, and mortality risk.

Conclusion

ERCP is not a risk factor for readmission among frail patients. However, frail patients are at higher risk for procedure-related complications, healthcare utilization, and mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Facciorusso A, Ramai D, Gkolfakis P et al. Comparative efficacy of different methods for difficult biliary cannulation in ERCP: A Systematic review and network meta-analysis. Gastrointest Endosc 2022;95:60–71.

    Article  PubMed  Google Scholar 

  2. Day LW, Lin L, Somsouk M. Adverse events in older patients undergoing ERCP: A systematic review and meta-analysis. Endosc Int Open 2014;2:28–36.

    Article  Google Scholar 

  3. Finkelmeier F, Tal A, Ajouaou M et al. ERCP in elderly patients: Increased risk of sedation adverse events but low frequency of post-ERCP pancreatitis. Gastrointest Endosc 2015;82:1051–1059.

    Article  PubMed  Google Scholar 

  4. Gilbert T, Neuburger J, Kraindler J et al. Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: An observational study. Lancet 2018;391:1775–1782.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Wleklik M, Uchmanowicz I, Jankowska EA et al. Multidimensional approach to frailty. Front Psychol 2020;11:564.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Bagshaw SM, Stelfox HT, McDermid RC et al. Association between frailty and short- and long-term outcomes among critically ill patients: A multicenter prospective cohort study. CMAJ 2014;186:95–102.

    Article  Google Scholar 

  7. Stefanaki C, Pervanidou P, Boschiero D, Chrousos GP. Chronic stress and body composition disorders: implications for health and disease. Hormones. 2018;17:33–43.

    Article  PubMed  Google Scholar 

  8. Chen X, Mao G, Leng SX. Frailty syndrome: An overview. Clin Interv Aging 2014;9:433–441.

    PubMed  PubMed Central  Google Scholar 

  9. Walston J, Buta B, Xue QL. Frailty screening and interventions: Considerations for clinical practice. Clin Geriatr Med 2018;34:25–38.

    Article  PubMed  PubMed Central  Google Scholar 

  10. HCUP Nationwide Readmissions Database (NRD). Healthcare Cost and Utilization Project (HCUP). 2019. Agency for Healthcare Research and Quality, Rockville, MD. https://www.hcup-us.ahrq.gov/nrdoverview.jsp.

  11. Moore BJ, White S, Washington R, Coenen N, Elixhauser A. Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: The AHRQ Elixhauser Comorbidity index. Med Care 2017;55:698–705.

    Article  Google Scholar 

  12. Quan H, Sundararajan V, Halfon P et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130–1139.

    Article  PubMed  Google Scholar 

  13. van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care 2009;47:626–633.

    Article  PubMed  Google Scholar 

  14. Malik AH, Yandrapalli S, Zaid S et al. Impact of frailty on mortality, readmissions, and resource utilization after TAVI. Am J Cardiol 2020;127:120–127.

    Article  PubMed  Google Scholar 

  15. Li C. Little’s test of missing completely at random. Stata J 2013;13:795–809.

    Article  Google Scholar 

  16. Royston P. Multiple imputation of missing values. Stata J 2004;4:227–241.

    Article  Google Scholar 

  17. Facciorusso A, Amato A, Crinò SF et al. Definition of a hospital volume threshold to optimize outcomes after drainage of pancreatic fluid collections with lumen-apposing metal stents: A nationwide cohort study. Gastrointest Endosc 2022;95:1158–1172.

    Article  PubMed  Google Scholar 

  18. Loperfido S, Angelini G, Benedetti G et al. Major early complications from diagnostic and therapeutic ERCP: A prospective multicenter study. Gastrointest Endosc 1998;48:1–10.

    Article  CAS  PubMed  Google Scholar 

  19. Keswani RN, Qumseya BJ, O’Dwyer LC, Wani S. Association between Endoscopist and center endoscopic retrograde cholangiopancreatography volume with procedure success and adverse outcomes: A systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2017;15:1866–1875.

    Article  PubMed  Google Scholar 

  20. Parikh MP, Garg R, Chittajallu V et al. Trends and risk factors for 30-day readmissions in patients with acute cholangitis: Analysis from the national readmission database. Surg Endosc 2021;35:223–231.

    Article  PubMed  Google Scholar 

  21. Jeurnink SM, Poley JW, Steyerberg EW, Kuipers EJ, Siersema PD. ERCP as an outpatient treatment: A review. Gastrointest Endosc 2008;68:118–123.

    Article  PubMed  Google Scholar 

  22. Nelson DB. Infectious disease complications of GI endoscopy: Part I, endogenous infections. Gastrointest Endosc 2003;57:546–556.

    Article  PubMed  Google Scholar 

  23. Lam SK, Tsui JK, Chan PK et al. How often does bacteraemia occur following endoscopic retrograde cholangiopancreatography (ERCP)? Endoscopy 1977;9:231–234.

    Article  CAS  PubMed  Google Scholar 

  24. Parker HW, Geenen JE, Bjork JT et al. A prospective analysis of fever and bacteremia following ERCP. Gastrointest Endosc 1979;25:102–103.

    Article  CAS  PubMed  Google Scholar 

  25. Siegel JH, Berger SA, Sable RA et al. Low incidence of bacteremia following endoscopic retrograde cholangiopancreatography (ERCP). Am J Gastroenterol 1979;71:465–468.

    CAS  PubMed  Google Scholar 

  26. ASGE Standards of Practice Committee, Khashab MA, Chithadi KV et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 2015;81:81–89.

    Article  Google Scholar 

  27. Thosani N, Zubarik RS, Kochar R et al. Prospective evaluation of bacteremia rates and infectious complications among patients undergoing single-operator choledochoscopy during ERCP. Endoscopy 2016;48:424–431.

    Article  PubMed  Google Scholar 

  28. Clegg A, Bates C, Young J et al. Development and validation of an electronic frailty index using routine primary care electronic health record data. Age ageing 2016;45:353–360.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

DR conceived and designed the study. AO, PG, and SC collected data. DR and JH conducted data analysis. DR drafted the manuscript. AT, MTB, CH, AR, and AF revised the manuscript for intellectual content. All authors approved the final version of the manuscript.

Corresponding author

Correspondence to Daryl Ramai.

Ethics declarations

Conflict of interest

Alessandro Repici is a consultant for Boston Scientific and Fuji. Daryl Ramai, Joseph Heaton, Andrew Ofosu, Paraskevas Gkolfakis, Saurabh Chandan, Alberto Tringali, Monique T. Barakat, Cesare Hassan, and Antonio Facciorusso have no conflicts of interest or financial ties to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 32 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ramai, D., Heaton, J., Ofosu, A. et al. Influence of Frailty in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography for Biliary Stone Disease: A Nationwide Study. Dig Dis Sci 68, 3605–3613 (2023). https://doi.org/10.1007/s10620-023-08013-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-023-08013-0

Keywords

Navigation